Self-Assembled Hyaluronic Acid Nanoparticles as a Potent Nanomedicine for Type 2 Diabetes

March 30, 2018


We are interested in research for the discovery of new target substances for thetreatment of diabetes.

Recently, we report that an self assembly Hyaluronic Acid Nanoparticles (HA-NP)  has therapeutic effects on Type 2 diabetes.

Treatment with HA-NPs in mice fed a high-fat diet suppressed macrophage infiltration into adipose tissue and activation of Nlrp3-ASC inflammasome, leading to reduced pro-inflammatory cytokines, normalized fasting blood glucose levels, and improved insulin sensitivity. These findings suggest that HA-NP could be a therapeutic agent for the treatment of type 2 diabetes







Share on Facebook
Share on Twitter
Please reload

The Laboratory of Molecular Biomedical Science.


  • Facebook Clean Grey
  • Twitter Clean Grey
  • LinkedIn Clean Grey
This site was designed with the
website builder. Create your website today.
Start Now